SANTA CLARITA, Calif., July 22, 2024 /PRNewswire/ — StimAire, a paradigm-shifting injectable neuromodulation company developing medical devices for obstructive sleep apnea (OSA), is pleased to announce the appointment of Arthur Rascon as Chief Operating Officer (COO), effective July 22,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.